Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,575 | 5 | 58.6% |
| Food and Beverage | $4,971 | 236 | 30.4% |
| Travel and Lodging | $1,620 | 8 | 9.9% |
| Consulting Fee | $90.00 | 1 | 0.6% |
| Education | $75.62 | 4 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $12,643 | 60 | $0 (2024) |
| GlaxoSmithKline, LLC. | $999.14 | 44 | $0 (2024) |
| CSL Behring | $640.71 | 36 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $219.93 | 12 | $0 (2024) |
| Grifols USA, LLC | $207.62 | 12 | $0 (2024) |
| GENZYME CORPORATION | $179.68 | 11 | $0 (2024) |
| PFIZER INC. | $174.36 | 22 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $162.04 | 9 | $0 (2024) |
| Horizon Therapeutics plc | $123.69 | 1 | $0 (2022) |
| ALK-Abello, Inc | $123.26 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $860.31 | 40 | AstraZeneca Pharmaceuticals LP ($222.13) |
| 2023 | $868.81 | 39 | GlaxoSmithKline, LLC. ($324.11) |
| 2022 | $726.14 | 32 | GlaxoSmithKline, LLC. ($252.19) |
| 2021 | $609.51 | 34 | GlaxoSmithKline, LLC. ($249.80) |
| 2020 | $336.63 | 20 | CSL Behring ($140.20) |
| 2019 | $510.59 | 30 | AstraZeneca Pharmaceuticals LP ($165.56) |
| 2018 | $243.93 | 14 | AstraZeneca Pharmaceuticals LP ($110.93) |
| 2017 | $12,176 | 45 | AstraZeneca Pharmaceuticals LP ($11,797) |
All Payment Transactions
254 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Immunology and Neurology | ||||||
| 10/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Respiratory | ||||||
| 09/09/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 08/30/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: RESPIRATORY | ||||||
| 08/27/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $8.51 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/20/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $19.76 | General |
| Category: Oncology / Rare Diseases | ||||||
| 08/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/07/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $16.03 | General |
| 08/01/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Immunology | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Respiratory | ||||||
| 07/09/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Immunology and Neurology | ||||||
| 07/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: RESPIRATORY | ||||||
| 06/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Respiratory | ||||||
| 06/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: IMMUNOLOGY | ||||||
| 05/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/07/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Immunology | ||||||
| 05/06/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 05/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.37 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/27/2024 | Pharming Healthcare, Inc. | — | Food and Beverage | In-kind items and services | $69.09 | General |
| 04/15/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $8.51 | General |
| Category: Respiratory | ||||||
| 04/12/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 673 | 6,433 | $160,087 | $103,058 |
| 2022 | 7 | 718 | 6,644 | $171,449 | $111,688 |
| 2021 | 9 | 786 | 7,060 | $183,318 | $122,989 |
| 2020 | 7 | 666 | 6,136 | $142,203 | $88,047 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 269 | 433 | $54,621 | $37,505 | 68.7% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 64 | 3,255 | $50,657 | $35,210 | 69.5% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 64 | 2,332 | $33,539 | $17,880 | 53.3% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 104 | 168 | $6,843 | $4,405 | 64.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 72 | $6,240 | $4,363 | 69.9% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 101 | 162 | $5,670 | $2,064 | 36.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $2,517 | $1,631 | 64.8% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 72 | 3,658 | $58,717 | $40,954 | 69.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 266 | 443 | $55,725 | $37,560 | 67.4% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 65 | 2,063 | $29,071 | $15,540 | 53.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 86 | 100 | $8,970 | $6,499 | 72.4% |
| 94375 | Test to measure rate of airflow | Office | 2022 | 106 | 185 | $7,600 | $5,119 | 67.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 24 | 24 | $5,382 | $3,737 | 69.4% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2022 | 99 | 171 | $5,985 | $2,278 | 38.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 274 | 458 | $57,457 | $41,407 | 72.1% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 72 | 3,275 | $52,564 | $38,413 | 73.1% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 67 | 2,141 | $30,187 | $15,851 | 52.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 99 | 135 | $12,120 | $8,130 | 67.1% |
| 94375 | Respiratory diagnostic testing (flow volume loop) | Office | 2021 | 108 | 210 | $8,623 | $5,715 | 66.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 29 | 29 | $6,503 | $4,637 | 71.3% |
| 95024 | Injection of allergenic extracts into skin for immediate reaction analysis | Office | 2021 | 12 | 586 | $5,293 | $3,758 | 71.0% |
| 95012 | Measurement of inhaled nitric oxide gas | Office | 2021 | 108 | 207 | $7,245 | $2,835 | 39.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 17 | 19 | $3,326 | $2,244 | 67.4% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2020 | 67 | 3,019 | $46,082 | $32,225 | 69.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 231 | 413 | $32,124 | $20,186 | 62.8% |
About Dr. Michael Rupp, MD
Dr. Michael Rupp, MD is a Allergy & Immunology healthcare provider based in Las Cruces, New Mexico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568414985.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Rupp, MD has received a total of $16,332 in payments from pharmaceutical and medical device companies, with $860.31 received in 2024. These payments were reported across 254 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($9,575).
As a Medicare-enrolled provider, Rupp has provided services to 2,843 Medicare beneficiaries, totaling 26,273 services with total Medicare billing of $425,783. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Allergy & Immunology
- Other Specialties Allergy
- Location Las Cruces, NM
- Active Since 05/16/2006
- Last Updated 01/30/2019
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1568414985
Products in Payments
- BEVESPI AEROSPHERE (Drug) $11,715
- NUCALA (Biological) $571.75
- DUPIXENT (Biological) $333.60
- TRELEGY ELLIPTA (Drug) $307.01
- Hizentra (Biological) $239.97
- Haegarda (Biological) $235.58
- FASENRA (Drug) $227.29
- AIRSUPRA (Drug) $219.05
- TEZSPIRE (Biological) $197.17
- Privigen (Biological) $148.70
- EUCRISA (Drug) $148.44
- ACTIMMUNE (Drug) $138.34
- Xembify (Biological) $132.88
- Odactra (Drug) $123.26
- Xhance (Drug) $116.64
- CUVITRU (Biological) $107.30
- GENERAL - THERAPIES (Device) $100.00
- SPIRIVA RESPIMAT (Drug) $90.33
- FASENRA (Biological) $80.96
- XOLAIR (Drug) $78.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.